Advanced Clinical hires Dr. Andreas Amrein to lead global development

Dr. Andreas Amrein, SVP APAC and Managing Director for Europe and Canada at Advanced Clinical

Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to announce that Dr. Andreas Amrein has joined the Executive Team as Senior Vice President of Asia-Pacific (APAC) and Japan as well as Managing Director for Europe and Canada.

Dr. Amrein will be instrumental to the firm’s expansion and strengthening of Advanced Clinical’s operations into the APAC region, such as offices in Singapore, Australia and Japan.

Dr. Amrein to oversee expansion at Advanced Clinical

Dr. Amrein will also oversee development and expansion opportunities for additional locations across Europe and Canada, complementing the organisation’s existing footprint inclusive of ten office locations in Europe as well as an office in Toronto, Canada.

With over 20 years of leadership experience, Dr. Amrein has led many teams across over 30 countries, like Fortune 100 companies (Novartis, Abbott and Shire) and dynamic start-ups.

“From my specialization in rapid commercial expansions, launches, transformations, partnerships and more across around the globe, I look forward to leveraging my knowledge to help Advanced Clinical further establish quality operations internationally,” said Dr. Amrein.

Dr. Amrein vital to business growth at Advanced Clinical

“We are excited to have Andreas on our team as we continue to expand into the APAC region and Japan,” said Julie Ross, President of Advanced Clinical.

“Andreas will be instrumental in accelerating business growth as we diversify our global clinical programs and elevate our clinical strategy for the clients and patients we serve.”

“After our successful entry into the region in 2021 combined with additional APAC office openings planned for 2022, Andreas will help elevate our presence across the APAC, European and Canadian regions as a leader in clinical research, FSP and resourcing services.”